DNA-based nano-sized systems for pharmaceutical and biomedical applications.

Makiya Nishikawa1, Sakulrat Rattanakiat, Yoshinobu Takakura

  • 1Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. makiya@pharm.kyoto-u.ac.jp

Summary

DNA nanotechnology enables new biomaterials, but their interaction with the body is unclear. This study reviews DNA molecule delivery and explores how structured DNA assemblies interact with Toll-like receptor-9 (TLR9) in cells.